α-glucosidase inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for α-glucosidase inhibitor, covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients [Phase 3]